Stomach Cancer Trial, Recruiting (NCT04022109)

Stomach Cancer Trial, Recruiting NCT04022109 Sponsor: University of Latvia Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04022109 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with gastric (stomach) cancer (Groups 1 & 2)
People who are currently having or have already had a camera examination of the upper digestive tract (an endoscopy) for medical reasons (Groups 3 & 5)
People aged 40–64 who are considered average risk and do not have any warning symptoms related to stomach cancer (Group 4)
People who are willing and motivated to take part in the study
People who are physically able to provide breath samples and complete the other procedures required by the study
People who have signed a consent form agreeing to participate

Who may not be able to join:

People who have another type of cancer that is currently active
People who have breathing difficulties or a blockage in their airways
People who are unable or unwilling to cooperate with the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hossam Haick, PhD, TECHNION, Israel Institute for Technology

Phone: +37129497500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04022109

Sponsor: University of Latvia

Phase: Not Applicable

Status: Recruiting

Condition: Stomach Cancer

Trial contact: +37129497500

More information: https://clinicaltrials.gov/study/NCT04022109

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with gastric (stomach) cancer (Groups 1 & 2)
People who are currently having or have already had a camera examination of the upper digestive tract (an endoscopy) for medical reasons (Groups 3 & 5)
People aged 40–64 who are considered average risk and do not have any warning symptoms related to stomach cancer (Group 4)
People who are willing and motivated to take part in the study
People who are physically able to provide breath samples and complete the other procedures required by the study
People who have signed a consent form agreeing to participate

Who may not be able to join:

People who have another type of cancer that is currently active
People who have breathing difficulties or a blockage in their airways
People who are unable or unwilling to cooperate with the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Latvia

Registry

ClinicalTrials.gov

Start date

1 November 2019

Est. completion

1 December 2022

Where this trial is recruiting

🇧🇷 Brazil 🇨🇱 Chile 🇨🇴 Colombia 🇱🇻 Latvia 🇺🇦 Ukraine

Primary endpoints

Characteristic VOC pattern identification for gastric cancer detection; Specific chemistry identification in the exhaled breath

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov